(Q39753974)

14 September 2017

Novel strategies of protecting non-cancer cells during chemotherapy: are they ready for clinical testing? (English)

1 reference

14 September 2017

1 reference

Zbyszek Darzynkiewicz

series ordinal

1

object named as

Zbigniew Darzynkiewicz

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 March 2011

1 reference

14 September 2017

1 reference

14 September 2017

2

1 reference

14 September 2017

3

1 reference

14 September 2017

107-108

1 reference

Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236559

Metformin induces both caspase-dependent and poly(ADP-ribose) polymerase-dependent cell death in breast cancer cells

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236559

Metformin in prostate cancer: two for the price of one.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236559

Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236559

Metformin and cancer: new applications for an old drug

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236559

Specific activation of the p53 pathway by low dose actinomycin D: a new route to p53 based cyclotherapy.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236559

Imatinib and its successors--how modern chemistry has changed drug development

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236559

Why Iressa failed: toward novel use of kinase inhibitors (outlook).

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236559

Cyclotherapy: protection of normal cells and unshielding of cancer cells

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236559

A Restriction Point for Control of Normal Animal Cell Proliferation

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236559

2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor

22 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21487161

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.18632/ONCOTARGET.249

0 references

1 reference

14 September 2017

PubMed publication ID

21487161

1 reference